Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma

被引:40
作者
Bandopadhayay, Pratiti [1 ,2 ,3 ]
Piccioni, Federica [2 ]
O'Rourke, Ryan [1 ,2 ]
Ho, Patricia [1 ,2 ]
Gonzalez, Elizabeth M. [1 ,2 ]
Buchan, Graham [1 ,2 ]
Qian, Kenin [1 ,2 ]
Gionet, Gabrielle [1 ,2 ]
Girard, Emily [4 ]
Coxon, Margo [4 ]
Rees, Matthew G. [2 ]
Brenan, Lisa [2 ]
Dubois, Frank [2 ,5 ]
Shapira, Ofer [2 ,5 ]
Greenwald, Noah F. [2 ,5 ,6 ]
Pages, Melanie [1 ,2 ]
Iniguez, Amanda Balboni [1 ,2 ]
Paolella, Brenton R. [2 ,5 ]
Meng, Alice [7 ]
Sinai, Claire [1 ,7 ]
Roti, Giovanni [1 ,2 ,8 ]
Dharia, Neekesh V. [1 ,2 ,3 ]
Creech, Amanda [2 ]
Tanenbaum, Benjamin [2 ]
Khadka, Prasidda [1 ,2 ,3 ]
Tracy, Adam [2 ]
Tiv, Hong L. [9 ,10 ]
Hong, Andrew L. [1 ,2 ,3 ]
Coy, Shannon [11 ]
Rashid, Rumana [11 ,12 ]
Lin, Jia-Ren [13 ,14 ]
Cowley, Glenn S. [2 ,15 ]
Lam, Fred C. [16 ]
Goodale, Amy [2 ]
Lee, Yenarae [2 ]
Schoolcraft, Kathleen [7 ]
Vazquez, Francisca [2 ]
Hahn, William C. [2 ,7 ,17 ]
Tsherniak, Aviad [2 ]
Bradner, James E. [2 ,7 ,17 ,18 ]
Yaffe, Michael B. [2 ,16 ]
Milde, Till [19 ,20 ,21 ]
Pfister, Stefan M. [19 ,22 ,23 ,24 ]
Qi, Jun [5 ]
Schenone, Monica [2 ]
Carr, Steven A. [2 ]
Ligon, Keith L. [2 ,11 ,17 ,25 ,26 ]
Kieran, Mark W. [1 ,3 ]
Santagata, Sandro [7 ,11 ]
Olson, James M. [4 ]
机构
[1] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA
[2] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
[3] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA
[4] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[5] Dana Farber Canc Inst, Div Canc Biol, Boston, MA 02115 USA
[6] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA
[7] Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA
[8] Univ Parma, Dept Med & Surg Hematol & BMT, Parma, Italy
[9] Expt Therapeut Core, Boston, MA USA
[10] Belfer Ctr Appl Canc Sci, Boston, MA USA
[11] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
[12] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA
[13] Harvard Med Sch, Lab Syst Pharmacol, Boston, MA 02115 USA
[14] Harvard Med Sch, Ludwig Ctr Canc Res Harvard, Boston, MA 02115 USA
[15] Johnson & Johnson, Janssen Res & Dev, Discovery Sci, Spring House, PA USA
[16] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA
[17] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[18] Novartis Inst Biomed Res, Basel, Switzerland
[19] Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany
[20] German Canc Res Ctr, CCU Pediat Oncol, Heidelberg, Germany
[21] Heidelberg Univ Hosp, Ctr Child & Adolescent Med, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany
[22] German Canc Consortium DKTK, Div Pediat Neurooncol, Heidelberg, Germany
[23] German Canc Res Ctr, Heidelberg, Germany
[24] Heidelberg Univ Hosp, Dept Pediat Hematol & Oncol, Heidelberg, Germany
[25] Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02115 USA
[26] Boston Childrens Hosp, Dept Pathol, Boston, MA USA
关键词
CANCER-CELLS; SENSITIVITY; TRANSCRIPTION; RESISTANCE; TUMORS; NEUROBLASTOMA; PROLIFERATION; CONNECTIVITY; PLASTICITY; STATE;
D O I
10.1038/s41467-019-10307-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
BET-bromodomain inhibition (BETi) has shown pre-clinical promise for MYC-amplified medulloblastoma. However, the mechanisms for its action, and ultimately for resistance, have not been fully defined. Here, using a combination of expression profiling, genome-scale CRISPR/Cas9-mediated loss of function and ORF/cDNA driven rescue screens, and cell-based models of spontaneous resistance, we identify bHLH/homeobox transcription factors and cell-cycle regulators as key genes mediating BETi's response and resistance. Cells that acquire drug tolerance exhibit a more neuronally differentiated cell-state and expression of lineage-specific bHLH/homeobox transcription factors. However, they do not terminally differentiate, maintain expression of CCND2, and continue to cycle through S-phase. Moreover, CDK4/CDK6 inhibition delays acquisition of resistance. Therefore, our data provide insights about the mechanisms underlying BETi effects and the appearance of resistance and support the therapeutic use of combined cell-cycle inhibitors with BETi in MYC-amplified medulloblastoma.
引用
收藏
页数:16
相关论文
共 61 条
[31]   Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas [J].
Kool, Marcel ;
Korshunov, Andrey ;
Remke, Marc ;
Jones, David T. W. ;
Schlanstein, Maria ;
Northcott, Paul A. ;
Cho, Yoon-Jae ;
Koster, Jan ;
Schouten-van Meeteren, Antoinette ;
van Vuurden, Dannis ;
Clifford, Steven C. ;
Pietsch, Torsten ;
von Bueren, Andre O. ;
Rutkowski, Stefan ;
McCabe, Martin ;
Collins, V. Peter ;
Backlund, Magnus L. ;
Haberler, Christine ;
Bourdeaut, Franck ;
Delattre, Olivier ;
Doz, Francois ;
Ellison, David W. ;
Gilbertson, Richard J. ;
Pomeroy, Scott L. ;
Taylor, Michael D. ;
Lichter, Peter ;
Pfister, Stefan M. .
ACTA NEUROPATHOLOGICA, 2012, 123 (04) :473-484
[32]   GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1 [J].
Kumar, Krishan ;
Raza, Sania S. ;
Knab, Lawrence M. ;
Chow, Christina R. ;
Kwok, Benjamin ;
Bentrem, David J. ;
Popovic, Relja ;
Ebine, Kazumi ;
Licht, Jonathan D. ;
Munshi, Hidayatullah G. .
SCIENTIFIC REPORTS, 2015, 5
[33]   BET bromodomain inhibition promotes neurogenesis while inhibiting gliogenesis in neural progenitor cells [J].
Li, Jingjun ;
Ma, Jing ;
Meng, Guofeng ;
Lin, Hong ;
Wu, Sharon ;
Wang, Jamie ;
Luo, Jie ;
Xu, Xiaohong ;
Tough, David ;
Lindon, Matthew ;
Rioja, Inmaculada ;
Zhao, Jing ;
Mei, Hongkang ;
Prinjha, Rab ;
Zhong, Zhong .
STEM CELL RESEARCH, 2016, 17 (02) :212-221
[34]   Genetic modifiers of the BRD4-NUT dependency of NUT midline carcinoma uncovers a synergism between BETis and CDK4/6is [J].
Liao, Sida ;
Maertens, Ophelia ;
Cichowski, Karen ;
Elledge, Stephen J. .
GENES & DEVELOPMENT, 2018, 32 (17-18) :1188-1200
[35]   Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance [J].
Liau, Brian B. ;
Sievers, Cem ;
Donohue, Laura K. ;
Gillespie, Shawn M. ;
Flavahan, William A. ;
Miller, Tyler E. ;
Venteicher, Andrew S. ;
Hebert, Christine H. ;
Carey, Christopher D. ;
Rodig, Scott J. ;
Shareef, Sarah J. ;
Najm, Fadi J. ;
van Galen, Peter ;
Wakimoto, Hiroaki ;
Cahill, Daniel P. ;
Rich, Jeremy N. ;
Aster, Jon C. ;
Suva, Mario L. ;
Patel, Anoop P. ;
Bernstein, Bradley E. .
CELL STEM CELL, 2017, 20 (02) :233-+
[36]   Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method [J].
Lin, Jia-Ren ;
Fallahi-Sichani, Mohammad ;
Sorger, Peter K. .
NATURE COMMUNICATIONS, 2015, 6
[37]  
Meyers R. M, 2017, NAT GENET, V350, P1096
[38]   HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment [J].
Milde, Till ;
Lodrini, Marco ;
Savelyeva, Larissa ;
Korshunov, Andrey ;
Kool, Marcel ;
Brueckner, Lena M. ;
Antunes, Andre S. L. M. ;
Oehme, Ina ;
Pekrun, Arnulf ;
Pfister, Stefan M. ;
Kulozik, Andreas E. ;
Witt, Olaf ;
Deubzer, Hedwig E. .
JOURNAL OF NEURO-ONCOLOGY, 2012, 110 (03) :335-348
[39]   Bromodomain and Extra-terminal (BET) Protein Inhibitors Suppress Chondrocyte Differentiation and Restrain Bone Growth [J].
Niu, Ningning ;
Shao, Rui ;
Yan, Guang ;
Zou, Weiguo .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (52) :26647-26657
[40]   Medulloblastoma Comprises Four Distinct Molecular Variants [J].
Northcott, Paul A. ;
Korshunov, Andrey ;
Witt, Hendrik ;
Hielscher, Thomas ;
Eberhart, Charles G. ;
Mack, Stephen ;
Bouffet, Eric ;
Clifford, Steven C. ;
Hawkins, Cynthia E. ;
French, Pim ;
Rutka, James T. ;
Pfister, Stefan ;
Taylor, Michael D. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (11) :1408-1414